• Strategy | We are buyers of every dip in Memphis PharmaWe are buyers of every dip in Memphis Pharma
• RAYA/RACC | RAYA/RACC acquisition is now most likely to go through at RAYA’s revised price of EGP9.0/share, exactly at the midpoint of our previously communicated price range
• PHAR | EIPICO III delay extends visibility gap, rotation toward MPCI and RMDA
• AMOC | Shareholder rotation reflects profitability headwinds
• EGAL | Riding the aluminum wave

In today's Pre-Session Views:

• Strategy | IRON share price reflects a 50:50 chance of monetizing 8 million sqm of land within the coming 12 months
• DSCW | Appoints IFA to value Helwan land ahead of expansion plan

In today's Pre-Session Views:

• Strategy | RACC will like trade within EGP8.5 to EGP9.5/share until RAYA announces the next move
• DSCW | Textile modernization and FDI inflows bolster DSCW’s strategic positioning should overshadow the stock's illiquidity discount
• P-fertilizers | Foreign capital reinforces Egypt’s strategic role in phosphate fertilizers
• Pharma | MPCI leads Egypt’s pharma rally with further upside potential
• MCQE | 3Q25 cement sales figures confirm MCQE as our top pick

In today's views

• Strategy | EGP17.5/l diesel sends an all-clear signal to MPC beyond 2025 
• ETRS | We are bullish on Egytrans/NOSCO mergerWe are bullish on Egytrans/NOSCO merger

• Strategy | Four deleveraging stories that will likely outperform in 2026 
• Macro/CSAG | USD/EGP at 45 and CSAG above its 52W high by early 2026 if Suez Canal traffic returns to normal
• LCSW | Turning windfall gains into momentum
• SKPC | 3Q25 results signal modest operating recovery
• EGBE, SAUD | set for their turn amid the rerating wave of banking stocks